期刊文献+

Mesenteric lymph system constitutes the second route in gut-liver axis and transports metabolism-modulating gut microbial metabolites 被引量:1

原文传递
导出
摘要 The gut-liver axis denotes the intricate connection and interaction between gut microbiome and liver, in which compositional and functional shifts in gut microbiome affect host metabolism. Hepatic portal vein of the blood circulation system has been thought to be the major route for metabolite transportation in the gut-liver axis, but the existence and importance of other routes remain elusive. Here, we perform metabolome comparison in blood circulation and mesenteric lymph systems and identify significantly shifted metabolites in serum and mesentery. Using cellular assays, we find that the majority of decreased metabolites in lymph system under high-fat diet are effective in alleviating metabolic disorders, indicating a high potential of lymph system in regulating liver metabolism. Among those, a representative metabolite, L-carnitine, reduces diet-induced obesity in mice. Metabolic tracing analysis identifies that L-carnitine is independently transported by the mesenteric lymph system, serving as an example that lymph circulation comprises a second route in the gut-liver axis to modulate liver metabolism. Our study provides new insights into metabolite transportation via mesenteric lymph system in the gut-liver axis, offers an extended scope for the investigations in host-gut microbiota metabolic interactions and potentially new targets in the treatment of metabolic disorders.
出处 《Journal of Genetics and Genomics》 SCIE CAS CSCD 2022年第7期612-623,共12页 遗传学报(英文版)
基金 supported by the National Natural Science Foundation of China (91857101) the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB29020000) the National Key Research and Development Program of China (2018YFC2000500)
  • 相关文献

参考文献3

二级参考文献132

  • 1George Kolios,Vassilis Valatas,Elias Kouroumalis.Role of Kupffer cells in the pathogenesis of liver disease[J].World Journal of Gastroenterology,2006,12(46):7413-7420. 被引量:76
  • 2Kengo Ichikawa,Takehiro Okabayashi,Hiromichi Maeda,Tsutomu Namikawa,Tatsuo Iiyama,Takeki Sugimoto,Michiya Kobayashi,Toshiki Mimura,Kazuhiro Hanazaki.Oral supplementation of branched-chain amino acids reduces early recurrence after hepatic resection in patients with hepatocellular carcinoma: a prospective study[J]. Surgery Today . 2013 (7)
  • 3Lise L. Gluud,Gitte Dam,Mette Borre,I?igo Les,Juan Cordoba,Giulio Marchesini,Niels K. Aagaard,Niels Risum,Hendrik Vilstrup.Oral Branched-Chain Amino Acids Have a Beneficial Effect on Manifestations of Hepatic Encephalopathy in a Systematic Review with Meta-Analyses of Randomized Controlled Trials12[J]. Journal of Nutrition . 2013 (8)
  • 4Lise Lotte Gluud,Gitte Dam,Mette Borre,I?igo Les,Juan Cordoba,Giulio Marchesini,Niels Kristian Aagaard,Hendrik Vilstrup.Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?[J]. Metabolic Brain Disease . 2013 (2)
  • 5Hiroki Nishikawa,Yukio Osaki,Eriko Iguchi,Yorimitsu Koshikawa,Soichiro Ako,Tadashi Inuzuka,Haruhiko Takeda,Jun Nakajima,Fumihiro Matsuda,Azusa Sakamoto,Shinichiro Henmi,Keiichi Hatamaru,Tetsuro Ishikawa,Sumio Saito,Akihiro Nasu,Ryuichi Kita,Toru Kimura.The Effect of Long-term Supplementation With Branched-chain Amino Acid Granules in Patients With Hepatitis C Virus-related Hepatocellular Carcinoma After Radiofrequency Thermal Ablation[J]. Journal of Clinical Gastroenterology . 2013 (4)
  • 6Kengo Ichikawa,Takehiro Okabayashi,Yasuo Shima,Tatsuo Iiyama,Yuka Takezaki,Masaya Munekage,Tsutomu Namikawa,Takeki Sugimoto,Michiya Kobayashi,Toshiki Mimura,Kazuhiro Hanazaki.Branched-chain amino acid-enriched nutrients stimulate antioxidant DNA repair in a rat model of liver injury induced by carbon tetrachloride[J]. Molecular Biology Reports . 2012 (12)
  • 7Yumie Takeshita,Toshinari Takamura,Yuki Kita,Hitoshi Ando,Teruyuki Ueda,Kenichiro Kato,Hirofumi Misu,Hajime Sunagozaka,Yoshio Sakai,Tatsuya Yamashita,Eishiro Mizukoshi,Masao Honda,Shuichi Kaneko.Beneficial effect of branched-chain amino acid supplementation on glycemic control in chronic hepatitis C patients with insulin resistance: Implications for type 2 diabetes[J]. Metabolism . 2012 (10)
  • 8Satoshi Miuma,Tatsuki Ichikawa,Kazuhiko Arima,Shigeyuki Takeshita,Toru Muraoka,Toshihisa Matsuzaki,Masashi Ootani,Hidetaka Shibata,Motohisa Akiyama,Eisuke Ozawa,Hisamitsu Miyaaki,Naota Taura,Fuminao Takeshima,Kazuhiko Nakao.Branched‐chain amino acid deficiency stabilizes insulin‐induced vascular endothelial growth factor mRNA in hepatocellular carcinoma cells[J]. J. Cell. Biochem. . 2012 (10)
  • 9Masashi Kuwahata,Hiroyo Kubota,Hiroaki Kanouchi,Shunsuke Ito,Aki Ogawa,Yukiko Kobayashi,Yasuhiro Kido.Supplementation with branched-chain amino acids attenuates hepatic apoptosis in rats with chronic liver disease[J]. Nutrition Research . 2012 (7)
  • 10AsamiHagiwara,MegumiNishiyama,SonokoIshizaki.Branched‐chain amino acids prevent insulin‐induced hepatic tumor cell proliferation by inducing apoptosis through mTORC1 and mTORC2‐dependent mechanisms[J]. J. Cell. Physiol. . 2012 (5)

共引文献60

同被引文献10

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部